vs
Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $379.6M, roughly 1.3× DIVERSIFIED HEALTHCARE TRUST). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -5.6%, a 12.4% gap on every dollar of revenue. On growth, DIVERSIFIED HEALTHCARE TRUST posted the faster year-over-year revenue change (-0.0% vs -1.7%). Over the past eight quarters, DIVERSIFIED HEALTHCARE TRUST's revenue compounded faster (1.2% CAGR vs -0.1%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DHC vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $379.6M | $493.8M |
| Net Profit | $-21.2M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | -12.6% | 9.9% |
| Net Margin | -5.6% | 6.8% |
| Revenue YoY | -0.0% | -1.7% |
| Net Profit YoY | 75.7% | 10.5% |
| EPS (diluted) | $-0.09 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $379.6M | $493.8M | ||
| Q3 25 | $388.7M | $492.9M | ||
| Q2 25 | $382.7M | $468.8M | ||
| Q1 25 | $386.9M | $458.4M | ||
| Q4 24 | $379.6M | $502.4M | ||
| Q3 24 | $373.6M | $511.2M | ||
| Q2 24 | $371.4M | $504.3M | ||
| Q1 24 | $370.8M | $495.1M |
| Q4 25 | $-21.2M | $33.7M | ||
| Q3 25 | $-164.0M | $71.7M | ||
| Q2 25 | $-91.6M | $39.3M | ||
| Q1 25 | $-9.0M | $20.7M | ||
| Q4 24 | $-87.4M | $30.5M | ||
| Q3 24 | $-98.7M | $19.4M | ||
| Q2 24 | $-97.9M | $-153.0M | ||
| Q1 24 | $-86.3M | $4.0M |
| Q4 25 | -12.6% | 9.9% | ||
| Q3 25 | -43.4% | 13.8% | ||
| Q2 25 | -24.5% | 12.8% | ||
| Q1 25 | -2.7% | 7.0% | ||
| Q4 24 | -26.1% | 7.8% | ||
| Q3 24 | -26.5% | 6.6% | ||
| Q2 24 | -23.0% | -31.3% | ||
| Q1 24 | -23.7% | 3.2% |
| Q4 25 | -5.6% | 6.8% | ||
| Q3 25 | -42.2% | 14.5% | ||
| Q2 25 | -23.9% | 8.4% | ||
| Q1 25 | -2.3% | 4.5% | ||
| Q4 24 | -23.0% | 6.1% | ||
| Q3 24 | -26.4% | 3.8% | ||
| Q2 24 | -26.3% | -30.3% | ||
| Q1 24 | -23.3% | 0.8% |
| Q4 25 | $-0.09 | $0.40 | ||
| Q3 25 | $-0.68 | $0.84 | ||
| Q2 25 | $-0.38 | $0.46 | ||
| Q1 25 | $-0.04 | $0.24 | ||
| Q4 24 | $-0.37 | $0.37 | ||
| Q3 24 | $-0.41 | $0.23 | ||
| Q2 24 | $-0.41 | $-1.84 | ||
| Q1 24 | $-0.36 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $105.4M | $375.2M |
| Total DebtLower is stronger | $2.4B | $570.5M |
| Stockholders' EquityBook value | $1.7B | $865.9M |
| Total Assets | $4.4B | $2.2B |
| Debt / EquityLower = less leverage | 1.47× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.4M | $375.2M | ||
| Q3 25 | $201.4M | $340.1M | ||
| Q2 25 | $141.8M | $224.7M | ||
| Q1 25 | $302.6M | $99.0M | ||
| Q4 24 | $144.6M | $229.9M | ||
| Q3 24 | $256.5M | $103.8M | ||
| Q2 24 | $265.6M | $19.4M | ||
| Q1 24 | $207.1M | $8.0M |
| Q4 25 | $2.4B | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $3.1B | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.7B | $865.9M | ||
| Q3 25 | $1.7B | $890.7M | ||
| Q2 25 | $1.9B | $833.8M | ||
| Q1 25 | $1.9B | $789.2M | ||
| Q4 24 | $2.0B | $764.9M | ||
| Q3 24 | $2.0B | $732.5M | ||
| Q2 24 | $2.1B | $706.5M | ||
| Q1 24 | $2.2B | $856.2M |
| Q4 25 | $4.4B | $2.2B | ||
| Q3 25 | $4.7B | $2.2B | ||
| Q2 25 | $4.8B | $2.1B | ||
| Q1 25 | $5.0B | $2.0B | ||
| Q4 24 | $5.1B | $2.2B | ||
| Q3 24 | $5.3B | $2.1B | ||
| Q2 24 | $5.3B | $2.0B | ||
| Q1 24 | $5.3B | $2.2B |
| Q4 25 | 1.47× | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 1.56× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-19.6M | $114.1M |
| Free Cash FlowOCF − Capex | $-166.4M | — |
| FCF MarginFCF / Revenue | -43.8% | — |
| Capex IntensityCapex / Revenue | 38.7% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-280.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-19.6M | $114.1M | ||
| Q3 25 | $-49.3M | $137.3M | ||
| Q2 25 | $53.0M | $137.2M | ||
| Q1 25 | $-3.2M | $-117.5M | ||
| Q4 24 | $112.2M | $133.0M | ||
| Q3 24 | $21.1M | $91.8M | ||
| Q2 24 | $44.3M | $107.0M | ||
| Q1 24 | $28.6M | $-125.2M |
| Q4 25 | $-166.4M | — | ||
| Q3 25 | $-89.8M | — | ||
| Q2 25 | $18.8M | — | ||
| Q1 25 | $-42.9M | — | ||
| Q4 24 | $-89.5M | — | ||
| Q3 24 | $-26.1M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $-18.1M | — |
| Q4 25 | -43.8% | — | ||
| Q3 25 | -23.1% | — | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | -11.1% | — | ||
| Q4 24 | -23.6% | — | ||
| Q3 24 | -7.0% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | -4.9% | — |
| Q4 25 | 38.7% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 8.9% | — | ||
| Q1 25 | 10.2% | — | ||
| Q4 24 | 53.1% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 12.6% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |